Bayer Aktiengesellschaft (VIE: BAYN)
Austria flag Austria · Delayed Price · Currency is EUR
19.02
+0.05 (0.24%)
Dec 20, 2024, 8:55 AM CET

Bayer Aktiengesellschaft Company Description

Bayer Aktiengesellschaft operates as a life science company worldwide.

It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough.

The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture.

This segment provides breeding, propagation, and production/processing of seeds, including seed dressing.

It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten.

It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers.

The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Bayer Aktiengesellschaft
Country Germany
Founded 1952
Industry Chemicals and Allied Products
Employees 96,931
CEO William Anderson

Contact Details

Address:
Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone 49 214 30 1
Website bayer.com

Stock Details

Ticker Symbol BAYN
Exchange Vienna Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 2800

Key Executives

Name Position
William Anderson Chief Executive Officer
Wolfgang Nickl Chief Financial Officer
Sebastian Guth Chief Operating Officer
Jost Reinhard Head of Investor Relations